(Q44008859)

28 November 2017

title

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. (English)

1 reference

28 November 2017

1 reference

1 reference

chronic heart failure

1 reference

6

1 reference

28 November 2017

Christian Torp-Pedersen

9

object named as

Christian Torp-Pedersen

1 reference

28 November 2017

5

Michel Komajda

1 reference

28 November 2017

8

Karl Swedberg

1 reference

28 November 2017

author name string

Philip A Poole-Wilson

1

1 reference

28 November 2017

John G F Cleland

2

1 reference

28 November 2017

Andrea Di Lenarda

3

1 reference

28 November 2017

Peter Hanrath

4

1 reference

28 November 2017

Willem J Remme

7

1 reference

28 November 2017

publication date

1 June 2002

1 reference

European Journal of Heart Failure

28 November 2017

published in

1 reference

28 November 2017

volume

4

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

321-329

1 reference

The epidemiology of heart failure

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Coronary artery disease as the cause of incident heart failure in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

The pharmacology of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Sample size calculation for complex clinical trials with survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900025-9

10.1016/S1388-9842(02)00025-9

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference